Chemokine Panel 1 (human) Gen. B Control Pack includes lyophilized controls for use with assays in the V-PLEX Chemokine Panel 1 Gen. B Kits. Individual analyte concentration is provided in the lot-specific certificate of analysis.
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
Application(s)
|
|
Cytokines & Chemokines
,
Immunology/Inflammation
|
|
Analyte(s)
|
|
Eotaxin, Eotaxin-3, IP-10, MCP-1, MCP-4, MDC, MIP-1α, MIP-1β, TARC
|
|
Species
|
|
Human
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Condition
|
|
2-8 °C
|
|
Schedule B Code
|
|
3822.19.0000
|
|
Product Description
|
Storage
|
Quantity per Kit
|
Chemokine Panel 1 (human) Gen. B Control 1
|
2-8 °C
|
5 vial (1 vial)
|
|
Chemokine Panel 1 (human) Gen. B Control 2
|
2-8 °C
|
5 vial (1 vial)
|
|
Chemokine Panel 1 (human) Gen. B Control 3
|
2-8 °C
|
5 vial (1 vial)
|
|
Product Inserts
|
|
|
Certificate of analysis
|
|
|
Title
|
Journal
|
Year
|
|
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
|
|
|
|
The inflammatory profile of cerebrospinal fluid, plasma, and saliva from patients with severe neuropathic pain and healthy controls-a pilot study
|
|
|
|
Anti-SARS-CoV-2 IgG from severely ill COVID-19 patients promotes macrophage hyper-inflammatory responses
|
|
|
|
Reliability of self-sampling for accurate assessment of respiratory virus viral and immunologic kinetics
|
|
|
|
Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters